These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 25738576)

  • 21. Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism.
    Zhang Z; Wang J; Zhu Y; Zhang H; Wang H
    Mol Med Rep; 2019 Nov; 20(5):4612-4622. PubMed ID: 31702040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
    Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of Combined Intervention of Electroacupuncture and Astragaloside IV on Myocardial Hypertrophy and TGF-β 1/Smad Signaling in Rats with Myocardial Fibrosis].
    Li JS; Zhu XY; Lu ML; Gao JH; Wang HX; Yu XC
    Zhen Ci Yan Jiu; 2017 Dec; 42(6):477-81. PubMed ID: 29318851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schisandrin A protects against isoproterenol‑induced chronic heart failure via miR‑155.
    Gao L; Li T; Li S; Song Z; Chang Y; Yuan L
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34812475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
    Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
    Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunit.
    Guo Z; Hu YH; Feng GS; Valenzuela Ripoll C; Li ZZ; Cai SD; Wang QQ; Luo WW; Li Q; Liang LY; Wu ZK; Zhang JG; Javaheri A; Wang L; Lu J; Liu PQ
    Acta Pharmacol Sin; 2023 Sep; 44(9):1777-1789. PubMed ID: 37186122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model.
    Palomer X; Alvarez-Guardia D; Rodríguez-Calvo R; Coll T; Laguna JC; Davidson MM; Chan TO; Feldman AM; Vázquez-Carrera M
    Cardiovasc Res; 2009 Mar; 81(4):703-12. PubMed ID: 19038972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
    Planavila A; Iglesias R; Giralt M; Villarroya F
    Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-κB and MAPK signaling pathways.
    Abdelhamid G; El-Kadi AO
    Free Radic Biol Med; 2015 May; 82():1-12. PubMed ID: 25614461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes.
    Li Y; Shen D; Tang X; Li X; Wo D; Yan H; Song R; Feng J; Li P; Zhang J; Li J
    Toxicol Lett; 2014 May; 226(3):257-63. PubMed ID: 24583048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardioprotection by acetylcholine: a novel mechanism via mitochondrial biogenesis and function involving the PGC-1α pathway.
    Sun L; Zhao M; Yu XJ; Wang H; He X; Liu JK; Zang WJ
    J Cell Physiol; 2013 Jun; 228(6):1238-48. PubMed ID: 23139024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-κb pathway.
    Mao HP; Wang XY; Gao YH; Chang YX; Chen L; Niu ZC; Ai JQ; Gao XM
    J Ethnopharmacol; 2016 Jun; 186():20-29. PubMed ID: 26970569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-κB signaling pathway in mice.
    Ma D; Zhang J; Zhang Y; Zhang X; Han X; Song T; Zhang Y; Chu L
    Int Immunopharmacol; 2018 Feb; 55():237-244. PubMed ID: 29274625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway.
    Al-Rasheed NM; Al-Oteibi MM; Al-Manee RZ; Al-Shareef SA; Al-Rasheed NM; Hasan IH; Mohamad RA; Mahmoud AM
    Drug Des Devel Ther; 2015; 9():3217-29. PubMed ID: 26150695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astragaloside IV inhibits isoprenaline‑induced cardiac fibrosis by targeting the reactive oxygen species/mitogen‑activated protein kinase signaling axis.
    Dai H; Jia G; Lu M; Liang C; Wang Y; Wang H
    Mol Med Rep; 2017 Apr; 15(4):1765-1770. PubMed ID: 28260010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D attenuates pro-inflammatory TNF-α cytokine expression by inhibiting NF-кB/p65 signaling in hypertrophied rat hearts.
    Al-Rasheed NM; Al-Rasheed NM; Bassiouni YA; Hasan IH; Al-Amin MA; Al-Ajmi HN; Mohamad RA
    J Physiol Biochem; 2015 Jun; 71(2):289-99. PubMed ID: 25929726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart.
    Yan W; Zhang H; Liu P; Wang H; Liu J; Gao C; Liu Y; Lian K; Yang L; Sun L; Guo Y; Zhang L; Dong L; Lau WB; Gao E; Gao F; Xiong L; Wang H; Qu Y; Tao L
    Basic Res Cardiol; 2013 May; 108(3):329. PubMed ID: 23460046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cinnamaldehyde activates AMPK/PGC-1α pathway via targeting GRK2 to ameliorate heart failure.
    Xu Z; Li M; Lyu D; Xiao H; Li S; Li Z; Li M; Xiao J; Huang H
    Phytomedicine; 2024 Oct; 133():155894. PubMed ID: 39089090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-κB and JAK/STAT signaling pathways in rats.
    Zhao L; Wu D; Sang M; Xu Y; Liu Z; Wu Q
    Int Immunopharmacol; 2017 Jul; 48():102-109. PubMed ID: 28499193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.